GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 247 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,253,000 | +501.5% | 179,928 | +182.2% | 0.04% | +680.0% |
| Q2 2022 | $2,037,000 | -24.0% | 63,767 | -17.6% | 0.01% | -16.7% |
| Q1 2022 | $2,681,000 | +18.4% | 77,400 | 0.0% | 0.01% | +50.0% |
| Q4 2021 | $2,265,000 | +14.9% | 77,400 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,972,000 | -27.3% | 77,400 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $2,711,000 | +771.7% | 77,400 | +914.4% | 0.01% | +500.0% |
| Q1 2021 | $311,000 | -5.8% | 7,630 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $330,000 | -23.6% | 7,630 | -2.7% | 0.00% | 0.0% |
| Q3 2020 | $432,000 | -10.9% | 7,840 | +2.0% | 0.00% | 0.0% |
| Q2 2020 | $485,000 | -89.4% | 7,690 | -91.4% | 0.00% | -93.3% |
| Q1 2020 | $4,567,000 | -29.5% | 89,400 | +9.7% | 0.02% | -6.2% |
| Q4 2019 | $6,478,000 | +63.8% | 81,500 | 0.0% | 0.02% | +45.5% |
| Q3 2019 | $3,954,000 | -3.4% | 81,500 | +4.8% | 0.01% | 0.0% |
| Q2 2019 | $4,092,000 | +11.6% | 77,800 | +12.3% | 0.01% | +10.0% |
| Q1 2019 | $3,668,000 | +74.2% | 69,300 | +35.1% | 0.01% | +42.9% |
| Q4 2018 | $2,106,000 | +6.0% | 51,300 | -1.9% | 0.01% | +40.0% |
| Q3 2018 | $1,987,000 | -15.9% | 52,300 | 0.0% | 0.01% | -28.6% |
| Q2 2018 | $2,364,000 | +31.6% | 52,300 | +40.6% | 0.01% | +40.0% |
| Q1 2018 | $1,797,000 | +63.1% | 37,200 | +32.9% | 0.01% | +66.7% |
| Q4 2017 | $1,102,000 | +26.8% | 28,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $869,000 | +13.4% | 28,000 | 0.0% | 0.00% | +50.0% |
| Q2 2017 | $766,000 | – | 28,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |